![]() |
Publications 2003125. MacIntyre CR, Kainer MA, Brown GV. A randomised, clinical trial comparing the effectiveness of hospital and community-based reminder systems for increasing uptake of influenza and pneumococcal vaccine in hospitalised patients aged 65 years and over. Gerontology 2003;49:33-40. [abstract] 126. McIntyre PB, Williams AH, Leask JE. Refusal of parents to vaccinate: dereliction of duty or legitimate personal choice? [editorial] Medical Journal of Australia 2003;178:150-1.[full text] 127. Torvaldsen S, Simpson JM, McIntyre P. Effectiveness of pertussis vaccination in New South Wales, Australia, 1996 to 1998. European Journal of Epidemiology 2003;18:63-9. [abstract] 128. MacIntyre CR, Burgess MA, Hull B, McIntyre PB. Hepatitis A vaccination options for Australia. Journal of Paediatrics and Child Health 2003;39:83-7. [abstract] 129. MacIntyre CR, Chu CP, Burgess MA. Use of hospitalisation and pharmaceutical prescribing data to compare the prevaccination burden of varicella and herpes zoster in Australia. Epidemiology and Infection 2003;131:675-82. [abstract]. 130. Burgess MA. Immunisation: a public health success. NSW Public Health Bulletin 2003;14:1-5. [full text] 131. Burgess MA. Tears often shed. (Feery Oration). NSW Public Health Bulletin 2003;14:5-8. [full text] 132. Hull BP, McIntyre PB. Mapping immunisation coverage and conscientious objectors to immunisation in NSW. NSW Public Health Bulletin 2003;14:8-12. [full text] 133. MacIntyre CR, Gay NJ, Hull B, Burgess M. Measles control in NSW Divisions of General Practice. NSW Public Health Bulletin 2003;14:13-7. [full text] 134. Lawrence GL, Campbell-Lloyd S, Rixon G. Monitoring adverse events following immunisation. NSW Public Health Bulletin 2003;14:21-4. [full text] 135. Wood N. Immunisation adverse events clinics. NSW Public Health Bulletin 2003;14:25-7. [full text] 136. Blumer C, Roche P, Spencer J, Lin M, Milton A, Bunn C, Gidding H, Kaldor J, Kirk M, Hall R, Della-Porta T, Leader R, Wright P, et al. Australia's notifiable disease status, 2001: annual report of the National Notifiable Diseases Surveillance System. Communicable Diseases Intelligence 2003;27:1-78. [full text] 137. Roche P, McIntyre P, Spencer J. Pneumococcal disease in Australia: current status and future challenges. A report of the workshop held at NCIRS 8-9 November, 2002. Communicable Diseases Intelligence 2003;27:79-84. [full text] 138. Brotherton JML, Delpech VC, Gilbert GL, Hatzi S, Paraskevopoulos PD, McAnulty JM. A large outbreak of influenza A and B on a cruise ship causing widespread morbidity. Epidemiology and Infection 2003;130:263-271. [abstract] 139. Beutels P, Gay NJ. Economic evaluation of options for measles vaccination strategy in a hypothetical Western European country. Epidemiology and Infection 2003;130:273-83. [abstract] 140. Burgess MA, Lester R. Meningococcal vaccines. Australian Prescriber 2003;26:56-8. [full text] 141. McIntyre P. Lessons from surveillance--solving the pertussis puzzle [editorial]. NSW Public Health Bulletin 2003;14:69-71. [full text] 142. Menzies R, Wang H, McIntyre P. Has pertussis increased in New South Wales over the past decade? An evaluation using hospitalisation and mortality data versus notifications 1988-2002. NSW Public Health Bulletin 2003;14:71-6. [full text] 143. Brotherton J, McAnulty J. A pertussis epidemic in NSW: how epidemiology reflects vaccination policy. NSW Public Health Bulletin 2003;14:77-81. [full text] 144. Torvaldsen S, McIntyre PB. Do variations in pertussis notifications reflect incidence or surveillance practices? A comparison of infant notification rates and hospitalisation data in NSW. NSW Public Health Bulletin 2003;14:81-4. [full text] 145. McIntyre PB, Gilmour R, Watson M. Differences in the epidemiology of invasive pneumococcal disease, metropolitan NSW, 1997-2001. NSW Public Health Bulletin 2003;14:85-9. [full text] 146. Gidding H. Australia's national serosurveillance program. NSW Public Health Bulletin 2003;14:90-3. [full text] 147. Brotherton JML, Bartlett MJ, Muscatello DJ, Campbell-Lloyd S, Stewart K, McAnulty JM. Do we practice what we preach? Health care worker screening and vaccination. American Journal of Infection Control 2003;31:144-50. [abstract] 148. Beutels P. On mandatory vaccination [letter] British Medical Journal Rapid responses June 2003. [full text]. 149. Lawrence GL, MacIntyre CR, Hull BP, McIntyre PB. Measles vaccination coverage among five-year-old children: implications for disease elimination in Australia. Australian and New Zealand Journal of Public Health 2003;27:413-8. [abstract] 150. Williams A, Forrest J, editors. Immunisation: communication and perception of risk. Summary of a workshop held in Melbourne, Australia, 5 May 2002. Sydney: NCIRS; 2003. [pdf version] 151. Horby P, Gilmour R, Wang H, McIntyre P. Progress towards eliminating Hib in Australia: an evaluation of Haemophilus influenzae type b prevention in Australia, 1 July 1993 to 30 June 2000. Communicable Diseases Intelligence 2003;27:324-41. [full text] 152. Lawrence G, Menzies R, Burgess M, McIntyre P, Wood N, Boyd I, Purcell P, Isaacs D. Surveillance of adverse events following immunisation: Australia 2000-2002. Communicable Diseases Intelligence 2003;27:307-23. [full text] Note: In tables showing age groups, the column labelled '7 years' should read ' >= 7 years' 153. Hull BP, Lawrence GL, McIntyre CR, McIntyre PB. Estimating immunisation coverage -- is the 'third dose assumption' still valid? Communicable Diseases Intelligence 2003;27:357-61. [full text] 154. Leask J. Anthrax row is not immune to wild claims of anti-vaccine lobby. Sydney Morning Herald; 13th February 2003. [full text] 155. Litt J, Burgess M. Varicella and varicella vaccination: an update. Australian Family Physician 2003;32:583-7. [abstract] 156. MacIntyre CR, Leask J. Immunization myths and realities: responding to arguments against immunization. Journal of Paediatrics and Child Health 2003;39:487-91. [abstract] 157. MacIntyre CR, Goebel K, Brown GV, Skull S, Starr M, Fulinfaw RO. A randomised, controlled clinical trial of the efficacy of family-based direct observation of anti-tuberculosis treatment in an urban, developed-country setting. International Journal of Tuberculosis and Lung Disease 2003;7:848-54. [abstract] 159. Leask J, McIntyre P. Public opponents of vaccination: a case study. Vaccine 2003;21:4700-3 [abstract] 160. Hull BP, Lawrence GL, MacIntyre CR, McIntyre PB. Immunisation coverage in Australia corrected for under-reporting to the Australian Childhood Immunisation Register. Australian and New Zealand Journal of Public Health 2003;27:533-8. [abstract] 161. Beutels P, Van Doorslaer E, Van Damme P, Hall J. Methodological issues and new developments in the economic evaluation of vaccines. Expert Review of Vaccines. 2003;2:89-100. [abstract] 162. Weerasinghe DP, MacIntyre CR. The seasonality of births and abortions in NSW. Medical Science Monitor 2003;9:CR534-40. [abstract] 163. Wood N, Thorley B. Towards global poliomyelitis eradication: the successes and challenges for a developed country. Journal of Paediatrics and Child Health 2003;39:647-50. [abstract] 164. Bonacruz-Kazzi G, McIntyre P, Hanlon M, Menzies R. Diagnostic testing and discharge coding for whooping cough in a children’s hospital. Journal of Paediatrics and Child Health 2003;39:586-90. [abstract] 165. Torvaldsen S, McIntyre PB. The effect of the preschool pertussis booster on national notifications of disease in Australia. Pediatric Infectious Disease Journal 2003;22:956-9. [abstract] 166. Forrest JM, Burgess M, Donovan T. A
resurgence of congenital rubella in Australia? Communicable Diseases
Intelligence 2003;27:533-6. [full
text]
Publications 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 |2007 | |2008| Back to top
|
|
|